Celldex (TCE1) Stock Statistics & Valuation Metrics

Celldex has a market cap or net worth of CHF2.48B. The enterprise value is CHF2.19K.

Celldex has ― shares outstanding. The number of shares has decreased by -2.65% in one year.

Celldex’s return on equity (ROE) is -0.49 and return on invested capital (ROIC) is -53.87%.

The current PE Ratio of Celldex is ―. Celldex’s PEG ratio is -0.12.

In the last 12 months, Celldex had revenue of 1.50M and earned -258.80M in profits. Earnings per share was -3.90.

In the last 12 months, operating cash flow was -235.57M and capital expenditures -6.25M, giving a free cash flow of -241.82M billion.

Celldex pays an annual dividend of ―, resulting in a dividend yield of ―

Celldex upcoming earnings date is Nov 11, 2026, After Close (Confirmed).

Celldex as a current ratio of 10.49, with Debt / Equity ratio of 0.69%

In the past 12 months, Celldex has paid 0.00 in taxes.

Celldex EV to EBITDA ratio is -6.97, with an EV/FCF ratio of -8.33.

Celldex has CHF717.59M in cash and marketable securities with CHF4.90M in debt, giving a net cash position of CHF712.68M billion.

Gross margin is -56850.89%, with operating margin of -19160.00%, and net profit margin of -17253.33%.

The average price target for Celldex is CHF47.11, which is 11.43% higher than the current price. The consensus rating is Strong Buy